AboutValuesWhy OA.mg?OA.mg PremiumExploreDataContact
Chrome ExtensionScholarMindChatGPT Plugin
ϟ
 
DOI: 10.1016/j.ctrv.2014.06.012
¤ OpenAccess: Hybrid
This work has “Hybrid” OA status. This means it is free under an open license in a toll-access journal.

Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma

David F. McDermott,Célèste Lebbe,F. Stephen Hodi,Michele Maio,Jeffrey S. Weber,Jedd D. Wolchok,John A. Thompson,Charles M. Balch

Ipilimumab
Medicine
Immunotherapy
2014
Loading...
    Cite this:
Generate Citation
Powered by Citationsy*
    “Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma” is a paper by David F. McDermott Célèste Lebbe F. Stephen Hodi Michele Maio Jeffrey S. Weber Jedd D. Wolchok John A. Thompson Charles M. Balch published in 2014. It has an Open Access status of “hybrid”. You can read and download a PDF Full Text of this paper here.
    OA.mgAbout UsOur ValuesWhy OA.mg? OA.mg PremiumChrome ExtensionChatGPT PluginPublic RoadmapChangelogContact UsFeedback?
    Privacy PolicyTerms of ServiceRefund Policy
    ContentOA.mg CoverageTop ListsOpen Access JournalsTopicsBlog
    ExploreGeographyEngineeringPoliSciGeologyPhilosophySociologyArtHistoryMathematicsPhysics
     PsychologyComputer ScienceBusinessEnvironmental ScienceChemistryMaterials ScienceMedicineBiologyEconomics
    OA.mg is built in Stockholm, London, and Seoul. We work hand in hand with the scientific community to advance the cause of Open Access. Feedback makes us better.